Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system [version 1; peer review: 4 approved]
Vasoactive intestinal peptide (VIP), a gut peptide hormone originally reported as a vasodilator in 1970, has multiple physiological and pathological effects on development, growth, and the control of neuronal, epithelial, and endocrine cell functions that in turn regulate ion secretion, nutrient abs...
Main Authors: | Mari Iwasaki, Yasutada Akiba, Jonathan D Kaunitz |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2019-09-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/8-1629/v1 |
Similar Items
-
Vasoactive Intestinal Peptide : Control of Hippocampal Neurogenesis
by: Zaben, Malik J.
Published: (2007) -
Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
by: Melody Hermel, et al.
Published: (2021-04-01) -
Vasoactive agents in acute mesenteric ischaemia in critical care. A systematic review [version 2; peer review: 1 approved, 2 approved with reservations]
by: Christopher A Brennan, et al.
Published: (2021-09-01) -
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence [version 1; peer review: 2 approved]
by: Antonella Conte, et al.
Published: (2020-01-01) -
Advances in the pathophysiology of adult-onset focal dystonias: recent neurophysiological and neuroimaging evidence [version 2; peer review: 2 approved]
by: Antonella Conte, et al.
Published: (2020-03-01)